CH
CEROW

CVI Holdings’s CERo Therapeutics Warrants CEROW Stock Holding History

CVI Holdings’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,673
Closed -$1.03K – 175
2023
Q4 		$1.03K Sell
43,673
-433
-1% -$14 ﹤0.01% 167
2023
Q3 		$3.16K Sell
44,106
-3,200
-7% -$229 0.01% 177
2023
Q2 		$2.89K Sell
47,306
-17,921
-27% -$778 ﹤0.01% 219
2023
Q1 		$3.26K Sell
65,227
-7,548
-10% -$340 ﹤0.01% 349
2022
Q4 		$2.86K Sell
72,775
-24,975
-26% -$1.31K ﹤0.01% 488
2022
Q3 		$14K Hold
97,750
– – ﹤0.01% 587
2022
Q2 		$10K Hold
97,750
– – ﹤0.01% 728
2022
Q1 		$19K Hold
97,750
– – ﹤0.01% 789
2021
Q4 		$42K Buy
+97,750
New +$45.1K ﹤0.01% 808

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

CVI Holdings's CEROW Position: Q1 2024 in Review

CVI Holdings sold out of CERo Therapeutics Warrants (CEROW) in Q1 2024, closing a stake of 43,673 shares — an estimated $1.03K sold.

CVI Holdings first reported a position in CEROW in Q4 2021 and held it in 9 quarters. The position peaked at $42K in Q4 2021. 37 funds tracked by Wall St. Rank hold CEROW as of Q1 2024.

  • CVI Holdings reported no remaining CERo Therapeutics Warrants position as of Q1 2024 after selling out during the quarter.
  • CVI Holdings sold 43,673 CERo Therapeutics Warrants shares in Q1 2024, an estimated $1.03K.
  • CVI Holdings first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 9 quarters.
  • CVI Holdings's CERo Therapeutics Warrants position peaked at $42K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2024.

Based on CVI Holdings's 13F filing for Q1 2024, filed 7 May 2024.